17/04/2026
This randomized controlled trial provides evidence that 6-month smartwatch-based atrial fibrillation (AF) screening enhances the detection rate of new onset AF compared with standard care in patients at elevated stroke risk.
Get the details in : https://bit.ly/4tkjjpm